Advocates Call on FDA to Remove Faulty Tests for Herpes

It is widely recognized among providers of STI screening that serology tests for Herpes Simplex Virus types 1 & 2 are highly inaccurate and often lead to false positives. SoContinueContinue reading “Advocates Call on FDA to Remove Faulty Tests for Herpes”

National Strategy for Herpes: A DHHS Strategic Plan in House FY 2022 Budget

Herpes Cure Advocacy confirms a national strategy and strategic plan for Herpes Simplex Virus Types 1 and 2 in the approved House FY 2022 budget. On page 245, the HouseContinueContinue reading “National Strategy for Herpes: A DHHS Strategic Plan in House FY 2022 Budget”